PLURACURE
PLURACURE is a biotechnology company focused on developing revolutionary treatments for chronic diseases that were previously considered incurable. They utilize a proprietary technology that combines advanced genomics, AI-driven drug discovery, and precision medicine to create targeted therapies. Their patient-centered approach emphasizes quality of life improvements and long-term outcomes, built on scientific excellence and a commitment to global accessibility. The company's research targets major chronic conditions including autoimmune disorders, neurodegenerative diseases, chronic inflammatory conditions, metabolic disorders, rare genetic diseases, and chronic pain syndromes. PLURACURE is led by its Founder & CEO, Suriyaa Rocky Sundararuban, and operates as a Suriyaa Inc.™ Company, based in Germany.
PLURACURE
PLURACURE is a biotechnology company focused on developing revolutionary treatments for chronic diseases that were previously considered incurable. They utilize a proprietary technology that combines advanced genomics, AI-driven drug discovery, and precision medicine to create targeted therapies. Their patient-centered approach emphasizes quality of life improvements and long-term outcomes, built on scientific excellence and a commitment to global accessibility. The company's research targets major chronic conditions including autoimmune disorders, neurodegenerative diseases, chronic inflammatory conditions, metabolic disorders, rare genetic diseases, and chronic pain syndromes. PLURACURE is led by its Founder & CEO, Suriyaa Rocky Sundararuban, and operates as a Suriyaa Inc.™ Company, based in Germany.